Jan Rowell looks at the growing use of digital twins which is being driven by the use of HPC and IOT
DataDirect Networks (DDN) has announced its intent to acquire Nexenta, a provider of software defined storage (SDS) for 5G and Internet of Things (IoT), creating the Nexenta by DDN division
Imagine a laboratory in the future where all devices and instruments communicate their status, activities and data with each other and with enterprise information systems. Data would be acquired without manual intervention.
As the Internet of Things approaches mainstream adoption and standards for data exchange among devices mature, smart labs can become a reality. In this white paper we discuss:
NI, IBM and SparkCognition have announced a collaboration to increase the efficiency of industrial machinery using a combination of Industrial Internet of Things (IIOT) and machine learning
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
